The Cost-Effectiveness of Dose Adjustment For Normal Eating (DAFNE) Structured Education in Type 1 Diabetes: An Update using the Sheffield Type 1 Diabetes Policy Model (Diabetes UK Professional Conference 13-15 March 2013)
posterposted on 27.02.2020, 14:55 by Jen Kruger, Alan Brennan, Praveen Thokala, Hasan Basarir, Simon Heller
A published economic evaluation suggested that DAFNE structured education for adults with Type 1 diabetes was cost-effective in comparison with no DAFNE over a 10-year time horizon (1). However, this study had several limitations including the exclusion of macrovascular diabetic complications.
The aim of the study was to provide an up-to-date estimate of the cost-effectiveness of DAFNE using the Sheffield Type 1 Diabetes Policy Model.
EthicsThere is no personal data or any that requires ethical approval
PolicyThe data complies with the institution and funders' policies on access and sharing
Sharing and access restrictionsThe data can be shared openly
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files